chloramphenicol has been researched along with diclofenac in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.33) | 18.7374 |
1990's | 1 (3.33) | 18.2507 |
2000's | 10 (33.33) | 29.6817 |
2010's | 12 (40.00) | 24.3611 |
2020's | 6 (20.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Dansette, PM; Fontana, E; Poli, SM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Miao, GX; Wang, YD; Yan, ZW; Zhang, LY | 1 |
Chang, TT; Chen, CL; Chen, WS; Fu, CW; Hsiao, PW; Li, WS; Tsai, HE | 1 |
Anderson, KS; Deshmukh, MG; Hollander, K; Ippolito, JA; Isaacs, F; Jorgensen, WL; Liang, Z; Lindenbach, BD; Liosi, ME; Miller, SJ; Reilly, RA; Spasov, KA; Stone, EA; Tirado-Rives, J; Zhang, CH; Zhang, S | 1 |
Cutrona, KJ; Henry, SP; Ippolito, JA; Jorgensen, WL; Krimmer, SG; Liosi, ME; Newton, AS; Schlessinger, J | 1 |
Cutrona, KJ; Henry, SP; Ippolito, JA; Jorgensen, WL; Krimmer, SG; Liosi, ME; Mohanty, J; Newton, AS; Olivarez, RA; Schlessinger, J | 1 |
Heimpel, H; Heit, W | 1 |
Neubert, RH; Rüttinger, HH; Schwarz, MA | 1 |
Axer-Siegel, R; Friling, R; Snir, M; Weinberger, D | 1 |
Doyle, SJ; Dua, HS; Pillai, CT; Sebai Sarhan, AR; Shah, S | 1 |
Chatziralli, IP; Moschos, MM; Pantazis, P; Rouvas, AA; Sergentanis, TN | 1 |
Cao, Z; Liu, X; Shi, X; Xu, J; Yang, Y; Zhan, Y; Zhao, H; Zhou, J | 1 |
Chan, EWL; Raja, I; Yap, JKY; Yee, ZY | 1 |
Cetina-Čižmek, B; Filipović-Grčić, J; Hafner, A; Juretić, M; Lovrić, J; Pepić, I | 1 |
Adjei, J; Adokoh, C; Barnie, S; Duncan, AE; Osei-Marfo, M; Sakyi, AG | 1 |
4 review(s) available for chloramphenicol and diclofenac
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced aplastic anaemia: clinical aspects.
Topics: Adolescent; Adult; Aged; Aging; Anemia, Aplastic; Child; Child, Preschool; Chloramphenicol; Colchicine; Diclofenac; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Humans; Leukocyte Count; Male; Medazepam; Middle Aged; Oxyphenbutazone; Penicillamine; Phenylbutazone; Prognosis; Quinacrine | 1980 |
3 trial(s) available for chloramphenicol and diclofenac
Article | Year |
---|---|
Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Chloramphenicol; Conjunctiva; Conjunctivitis; Dexamethasone; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Pain, Postoperative; Polymyxin B; Safety; Strabismus; Wound Healing | 2000 |
The epithelial flap for photorefractive keratectomy.
Topics: Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Chloramphenicol; Debridement; Diclofenac; Epithelium, Corneal; Female; Humans; Lasers, Excimer; Male; Middle Aged; Myopia; Pain, Postoperative; Photorefractive Keratectomy; Refraction, Ocular; Surgical Flaps; Treatment Outcome; Visual Acuity | 2001 |
Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cell Count; Chloramphenicol; Cornea; Dexamethasone; Diclofenac; Drug Combinations; Drug Therapy, Combination; Endothelial Cells; Endothelium, Corneal; Female; Fovea Centralis; Humans; Macula Lutea; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Prospective Studies; Visual Acuity | 2012 |
23 other study(ies) available for chloramphenicol and diclofenac
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Synthesis, in vitro ADME profiling and in vivo pharmacological evaluation of novel glycogen phosphorylase inhibitors.
Topics: Animals; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epinephrine; Glycogen Phosphorylase; Hep G2 Cells; Hepatocytes; Humans; Hypoglycemic Agents; Indoles; Mice; Molecular Structure; Rats; Structure-Activity Relationship | 2020 |
Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis.
Topics: Animals; Animals, Genetically Modified; Breast Neoplasms; Catalysis; Cell Line, Tumor; Enzyme Inhibitors; Female; Focal Adhesion Protein-Tyrosine Kinases; Glycoproteins; Humans; Integrins; Isoenzymes; Molecular Docking Simulation; Neoplasm Metastasis; NF-kappa B; Paxillin; Phosphorylation; Sialyltransferases; Signal Transduction; Talin; Zebrafish | 2021 |
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency.
Topics: | 2021 |
Conversion of a False Virtual Screen Hit into Selective JAK2 JH2 Domain Binders Using Convergent Design Strategies.
Topics: | 2022 |
Insights on JAK2 Modulation by Potent, Selective, and Cell-Permeable Pseudokinase-Domain Ligands.
Topics: Humans; Janus Kinase 2; Janus Kinases; Ligands; Mutation; Myeloproliferative Disorders; Signal Transduction; STAT Transcription Factors | 2022 |
Application of capillary electrophoresis of characterizing interactions between drugs and bile salts. Part I.
Topics: Atenolol; Bile Acids and Salts; Chloramphenicol; Diclofenac; Electrophoresis, Capillary; Glycochenodeoxycholic Acid; Glycocholic Acid; Glycodeoxycholic Acid; Hydrogen-Ion Concentration; Micelles; Models, Chemical; Osmolar Concentration; Pharmaceutical Preparations; Propranolol; Quinine; Salicylates; Taurocholic Acid; Tetracycline | 1996 |
Adsorption behavior and mechanism of chloramphenicols, sulfonamides, and non-antibiotic pharmaceuticals on multi-walled carbon nanotubes.
Topics: Adsorption; Anti-Bacterial Agents; Carbamazepine; Chloramphenicol; Diclofenac; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Nanotubes, Carbon; Sulfonamides; Waste Disposal, Fluid; Water Pollutants, Chemical | 2016 |
Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cefuroxime; Chloramphenicol; Diclofenac; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ibuprofen; Mefenamic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus | 2017 |
Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
Topics: Administration, Ophthalmic; Animals; Biopharmaceutics; Cell Line; Chloramphenicol; Dexamethasone; Diclofenac; Drug Compounding; Dynamic Light Scattering; Electric Impedance; Epithelium, Corneal; Excipients; Female; Glycerol; Humans; Male; Ocular Absorption; Ophthalmic Solutions; Permeability; Pharmaceutical Preparations; Poloxamer; Polyethylene Glycols; Polysorbates; Surface-Active Agents; Sus scrofa; Technology, Pharmaceutical; Time Factors; Timolol | 2018 |
Analysis and risk assessment of pharmaceutical residues in fish from three water bodies in Ghana.
Topics: Animals; Catfishes; Chloramphenicol; Diclofenac; Environmental Monitoring; Estrone; Ghana; Pharmaceutical Preparations; Primidone; Progesterone; Risk Assessment; Rivers; Water; Water Pollutants, Chemical | 2023 |